Home News & Events Events Events Page tools Share Share Share on FacebookShare on XShare on LinkedinShare on Bluesky Print Search Email Accessibility Filter events Filter events by clicking within the ‘Category’ drop-down list. Category - Any - Industry Webinars Workshop Workshop Beginners/Intermediate Online NONMEM/PDx-Pop Workshop Date 19 May 2026 - 20 May 2026 Time 08:00 - 18:00 Location Online/Webex Timezone America/New York Workshop Advanced Online NONMEM/PDx-Pop Workshop Date 21 May 2026 Time 09:00 - 17:00 Location Online/Webex Timezone America/New York Webinars Insights into first-in-human study design of oligonucleotides Date 27 May 2026 Time 15:00 - 16:00 Location Webinar Timezone BST - Europe/Dublin Industry ASCO 2026 Date 29 May 2026 - 2 June 2026 Time 08:00 - 18:00 Location Chicago, IL, USA Timezone America/Chicago ICON will exhibit | Booth #35093 Workshop New and Advanced Features of NONMEM 7.6 Workshop Date 1 June 2026 Time 09:00 - 17:00 Location Dubrovnik, Croatia Timezone Europe/Bratislava Industry CYTO Date 6 June 2026 - 10 June 2026 Time 08:00 - 18:00 Location West Palm Beach, FL, USA Timezone EDT - America/New York ICON will Exhibit | Booth #715 Industry OCT UK and Ireland Date 9 June 2026 - 10 June 2026 Time 08:00 - 18:00 Location London, UK Timezone Europe/London ICON will Exhibit | Booth #42 Industry DIA Annual Meeting Date 14 June 2026 - 18 June 2026 Time 08:00 - 18:00 Location Philadelphia, PA, USA Timezone EDT - America/New York ICON will Exhibit | Booth #1426 Industry PCMG Date 16 June 2026 - 17 June 2026 Time 08:00 - 18:00 Location Berlin, Germany Timezone Europe/Berlin ICON will Sponsor Previous 1 2 3 Next In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events ASCO 2026 Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Solutions Webinars Solutions Industry events Solutions Workshops What's happening in ICON ICON Plc The RACE Act changed pediatric oncology in the US. The EMA’s proposed MoA PIP requirements could do the same in Europe. So what does this mean for sponsors? ICON’s Regulatory Affairs (Graham Bell) and Pediatrics (Jacqu... 16 Apr View post View webpage ICON Plc Proposed requirements for Mechanism of Action based PIPs are coming. Right now, they’re still developing. ICON can help sponsors position to stay ahead of the curve and benefit from incentives while meeting pediatric obl... 16 Apr 1 View post View webpage ICON Plc ICON will participate in BIO Korea 2026 from 28 to 30 April in Seoul, South Korea. The event brings together leaders in biotechnology and healthcare to discuss scientific innovation and industry collaboration. Visit ICO... 16 Apr View post View webpage ICON Plc Strong engagement, open dialogue, and a shared focus on the future. Last week, ICON CEO, Barry Balfe, connected with teams in our São Paulo and Mexico City offices, hosting a series of highly engaged town halls. The vis... 15 Apr View post ICON Plc Patient safety and data integrity are the primary concerns in early phase clinical trials. In the US sponsors generally follow one of two standards sets when conducting early phase trials: Good Manufacturing Practice (GM... 15 Apr View post View webpage ICON Plc In 2025, the EMA and FDA each released regulatory guidance that impacts the development and approval processes for biosimilars, such as by waiving the need for comparative clinical efficacy studies in some circumstances.... 15 Apr 1 View post View webpage ICON Plc ICON is excited to sponsor RAPS Euro Convergence 2026, taking place 5–8 May in Lisbon. Visit us at booth \#21 to meet our team and discuss how ICON combines expertise and experience with the latest in productivity tool... 14 Apr View post View webpage ICON Plc Clinical research is evolving at pace and so is the role of the Clinical Research Associate. From increased use of technology and data, to more strategic site partnerships, today’s CRA plays a critical role in deliverin... 14 Apr View post View webpage ICON Plc On 15 April at 12:00 pm, join ICON’s Alan Baldridge at the GLP-1-Based Therapeutics Summit for his session, “Is there anything GLP‑1s can’t do? Unlocking the next generation of metabolic treatments.” He will offer a fo... 14 Apr View post View webpage ICON Plc ICON is once again sponsoring and presenting at #OCTEU26 on 6–7 May in Barcelona, which focuses on the evolving needs of the biotechnology sector within clinical research. The meeting highlights scientific innovation alo... 13 Apr View post View webpage ICON Plc Selecting the right pediatric HRQoL instrument is no longer optional. It’s a regulatory expectation. Our latest blog breaks down a six criterion framework to guide sponsors in making defensible, patient focused choices, ... 10 Apr 3 View post View webpage ICON Plc In many neurodegenerative diseases, changes in the brain begin years before clinical signs emerge. New technologies and methods are enabling earlier diagnosis and intervention. Explore how pragmatic adoption of these inn... 10 Apr 2 View post View webpage
